semaglutide asa guidelines 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists ASA Advises No Longer Holding

Por eso las organizaciones han pedido mayor transparencia sobre el estado real de las patentes farmacuticas y reglas ms claras que permitan producir medicamentos equivalentes de calidad y menor costo

The guide on drinking while on tirzepatide addresses how alcohol interacts with the medication and whether it affects dosing efficacy

Risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients prescribed semaglutide Novo Nordisk A new observational study reported for the first time a potential link between Novo Nordisks GLP-1 drugs Ozempic and Wegovy and an eye condition that can cause vision loss

Pharmacokinetics and pharmacodynamics of a polyethylene glycol (PEG)-conjugated GLP-receptor agonist once weekly in Chinese patients with type 2 diabetes